Global Sepsis Diagnostics Market 2021-2028

October 11, 2021

Global Piling Machine Market 2021-2028

October 13, 2021

Global Platelet Aggregation Devices Market 2021-2028

Name: Global Platelet Aggregation Devices Market 2021-2028
SKU: 781
Availability: InStock

$5195 – $7195

Single User Licence

$5195

Report is e-mailed to one user in encrypted PDF form without printing rights.

Team Licence

$5695

Report is e-mailed to up to 5 users in encrypted PDF form without printing rights.

Enterprise Licence

$7195

Report is e-mailed in free PDF form, can be shared with number of users with printing rights.

Select License Type

Clear

SKU: N/A Categories: Test, Uncategorized

Platelet aggregation is a process where human platelet cells are involved in hemostasis, bleeding to repair, and vessel constriction. It plays a crucial role in inflammation and other pathological situations. Platelet aggregation test involves venipuncture in an anti-coagulant medium. This is followed by centrifugation to produce plasma which is rich in platelets, where aggregometer are used to study the platelet aggregation.

Select License Type	Single User Licence, Team Licence, Enterprise Licence

Report Summary

Revolutionize the way you engage with data through our cutting-edge interactive dashboard(Click to enlarge)

Platelet aggregation is a process where human platelet cells are involved in hemostasis, bleeding to repair, and vessel constriction. It plays a crucial role in inflammation and other pathological situations. Platelet aggregation test involves venipuncture in an anti-coagulant medium. This is followed by centrifugation to produce plasma which is rich in platelets, where aggregometer are used to study the platelet aggregation.
Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fueling the growth of the global market.
There is an increasing incidence of heart problems, such as stroke and coronary heart disease, which cause a global burden of cardiac death that has increased the growth of the platelet aggregation devices market. For instance, according to the American Heart Association Research Report, cardiovascular disease is listed as the underlying cause of death, and it accounts for nearly 836,546 deaths in the United States. This is nearly 1 out of every 3 deaths in the country. About 2,300 Americans die of cardiovascular disease each day, which is an average of 1 death every 38 seconds. The significant increase in the number of people suffering from cardiovascular diseases ultimately increases the use of platelet aggregation devices to study platelet aggregation worldwide and drives the market over the forecast period

Segment Analysis

On the basis of end user, the global platelet aggregation devices market is classified into standalone hospitals, diagnostic laboratories, research & academic institutes, and other end users (blood banks & pharmaceutical-biotechnology companies). Standalone hospitals segment is expected to account for the largest share of the global market in 2020. This segment is expected to grow at the highest CAGR in the next five years as well, owing to benefits offered by hospitals in conducting platelet aggregation testing procedure, large patient population base for target diseases (such as bleeding disorders, cardiovascular diseases, and arthritis), growing public-private investments for development and modernization of healthcare infrastructure, and increasing number of hospitals across developing countries.

Regional Analysis

Market Size by Region

Upgrade report license to gain access to the complete analysis

North America Market Size (USD Million) 2019-2028

North America (particularly the U.S.) is poised to be the fastest growing region in global platelet aggregation devices market during the forecast period. North American region has become attractive destination for companies engaged in the development, manufacture, and distribution of platelet aggregation products. Factors such as growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders are offering high-growth opportunities for players active in the North American platelet aggregation devices market.
The country is also witnessing a greater impact of COVID-19, affecting many markets, including the market studied. The market studied was largely impacted at the beginning of the year due to the cancellation of diagnostic procedures. However, there is a recent positive trend, as the studies of the effect of COVID-19 on platelet aggregation are booming throughout the country, and the demand for the devices is rising compared to the beginning of the year.

Upgrade report license to gain access to the complete analysis

Regional Analysis

North America Market Size by Product Type

Upgrade report license to gain access to the complete analysis

North America Market Size by Application

Upgrade report license to gain access to the complete analysis

North America Market Size by End User

Table of Content

1. Executive Summary
  1.1.	 Market Insights
  1.2.	 Market Outlook
  1.3.	 Segmental Insights

2. Market Research Methodology
  2.1.	 Research methodology and design
  2.2.	 Sample selection
  2.3.	 Reliability and validity

3. Market Analysis
  3.1.	 Market size and growth rates
  3.2.	 Market growth drivers, market dynamics and trends 
  3.3.	 Industry value chain analysis
  3.4.	 Market scenarios and opportunity forecasts
  3.5.	 Relevant markets
  3.6.	 The new frontiers of growth 
  3.7.	 Emerging market needs and challenges
  3.8.	 Industry Analysis – Porter’s
     3.8.1.	Threat of new entrants
     3.8.2.	Bargaining power of suppliers
     3.8.3.	Bargaining power of buyers
     3.8.4.	Threat of substitutes
     3.8.5.	Competitive rivalry
  3.9.	 PEST Analysis
     3.9.1.	Political/legal landscape
     3.9.2.	Social landscape
     3.9.3.	Technological landscape

4. COVID 19 Crisis Analysis
  4.1.	 Statistics and probable future impact
  4.2.	 Scenarios and path forward
  4.3.	 Sector specific impact
  4.4.	 Industry transformation
  4.5.	 Action plan for industry players
  4.6.	 Supply chain: actions to consider
  4.7.	 Initiatives prioritization
  4.8.	 Strategic crisis-action plan
  4.9.	 The next normal
    4.9.1.	Supply chain
    4.9.2.	Regulations
    4.9.3.	Organizations 

5. Market Breakdown – by Product Type
  5.1.	 Introduction
  5.2.	 Systems
  5.3.	 Reagents
  5.4.	 Consumables and Accessories
  
6. Market Breakdown – by Application
  6.1.	 Introduction
  6.2.	 Clinical Applications
   6.2.1.  Cardiovascular Applications
   6.2.2.  Orthopedic Applications
   6.2.3.  Other Clinical Applications
  6.3.    Research Applications

7. Market Breakdown – by End User
  7.1.	  Introduction
  7.2.    Standalone Hospitals
  7.3.    Diagnostic Laboratories
  7.4.    Research and Academic Institutes
  7.5.    Other End Users

8. Market Breakdown by Geography
 8.1.   North America
    8.1.1.  North America Pre-Insulated Pipe Market, 2019-2028 
    8.1.2.  North America Pre-Insulated Pipe Market, by Type of Pipe
    8.1.3.  North America Pre-Insulated Pipe Market, by Material Type
    8.1.4.  North America Pre-Insulated Pipe Market, by Pipe Configuration
    8.1.5.  North America Pre-Insulated Pipe Market, by Installation
    8.1.6.  North America Pre-Insulated Pipe Market, by Pipe End-Use Industry
    8.1.7.  North America Pre-Insulated Pipe Market, by Country
            8.1.7.1.  U.S.
            8.1.7.2.  Canada
            8.1.7.3.  Mexico

 8.2. South America
   8.2.1.  South America Pre-Insulated Pipe Market, 2019-2028 
   8.2.2.  South America Pre-Insulated Pipe Market, by Type of Pipe
   8.2.3.  South America Pre-Insulated Pipe Market, by Material Type
   8.2.4.  South America Pre-Insulated Pipe Market, by Pipe Configuration
   8.2.5.  South America Pre-Insulated Pipe Market, by Installation
   8.2.6.  South America Pre-Insulated Pipe Market, by Pipe End-Use Industry
   8.2.7.  South America Pre-Insulated Pipe Market, by Country
          8.2.7.1.   Brazil
          8.2.7.2.   Argentina
          8.2.7.3.   Others
 8.3.  Europe
  8.3.1.  Europe Pre-Insulated Pipe Market, 2019-2028 
  8.3.2.  Europe Pre-Insulated Pipe Market, by Type of Pipe
  8.3.3.  Europe Pre-Insulated Pipe Market, by Material Type
  8.3.4.  Europe Pre-Insulated Pipe Market, by Pipe Configuration
  8.3.5.  Europe Pre-Insulated Pipe Market, by Installation
  8.3.6.  Europe Pre-Insulated Pipe Market, by Pipe End-Use Industry
  8.3.7.  Europe Pre-Insulated Pipe Market, by Country
        8.3.7.1.  Germany 
        8.3.7.2.   France
        8.3.7.3.   U.K.
        8.3.7.4.   Russia
        8.3.7.5.   Italy
        8.3.7.6.   Spain
        8.3.7.7.   Sweden
        8.3.7.8.   Netherlands
        8.3.7.9.   Others

 8.4.  Asia-Pacific
  8.4.1. APAC Pre-Insulated Pipe Market, 2019-2028 
  8.4.2. APAC Pre-Insulated Pipe Market, by Type of Pipe
  8.4.3. APAC Pre-Insulated Pipe Market, by Material Type
  8.4.4. APAC Pre-Insulated Pipe Market, by Pipe Configuration
  8.4.5. APAC Pre-Insulated Pipe Market, by Installation
  8.4.6. APAC Pre-Insulated Pipe Market, by Pipe End-Use Industry
  8.4.7. APAC Pre-Insulated Pipe Market, by Country
      8.4.7.1   China
      8.4.7.2   Japan
      8.4.7.3   South Korea
      8.4.7.4   India
      8.4.7.5   Australia
      8.4.7.6   Others

 8.5.  Middle East & Africa
  8.5.1. MEA Pre-Insulated Pipe Market, 2019-2028 
  8.5.2. MEA Pre-Insulated Pipe Market, by Type of Pipe
  8.5.3. MEA Pre-Insulated Pipe Market, by Material Type
  8.5.4. MEA Pre-Insulated Pipe Market, by Pipe Configuration
  8.5.5. MEA Pre-Insulated Pipe Market, by Installation
  8.5.6. MEA Pre-Insulated Pipe Market, by Pipe End-Use Industry
  8.5.7. MEA Pre-Insulated Pipe Market, by Country
    8.5.7.1  South Africa
    8.5.7.2  Saudi Arabia
    8.5.7.3  UAE
    8.5.7.4  Qatar
    8.5.7.5  Israel
    8.5.7.6  Others

9. Competitive Landscape
 9.1.  Competitive situation and trends
 9.2.  Company market positioning
 9.3.  Vendor landscape
 9.4.  Company geographical presence analysis
 9.5.  Recent market and industry developments 
  9.5.1. New product developments and announcements
  9.5.2. Agreements, partnerships, joint ventures, and collaborations
  9.5.3. Mergers and acquisitions and major PE deals

10. Company Profiles
  . Company overview
  . Financial performance
  . Product benchmarking
  . Strategic initiatives 
 10.1.	 Aggredyne, Inc.
 10.2.	 Bio/Data Corporation
 10.3.	 F. Hoffman-La Roche Ltd.
 10.4.	 Grifols
 10.5.	 Haemonetics Corporation
 10.6.	 Helena Laboratories Corporation
 10.7.	 Labcorp
 10.8.	 Matis Medical
 10.9.	 Sentinel Diagnostics
 10.8.	 Siemens 
 10.9.	 Sysmex Corporation
 10.10.	 Werfen  
 10.13.	 Others

Request Sample

Name (required)

Company (required)

Job Title (required)

Your Email (required)

Select the country (required)

Phone No (required)

Field of Interest

Global Sepsis Diagnostics Market 2021-2028

Global Piling Machine Market 2021-2028

Global Platelet Aggregation Devices Market 2021-2028

Report Summary

Table of Content

Request Sample

Buy Now

Related products

Global Construction & Heavy Equipment Telematics Market 2021-2028